Chad M. Amosson

Dosimetric predictors of xerostomia for head-and-neck cancer patients treated with the smart (simultaneous modulated accelerated radiation therapy) boost technique

Chad M. Amosson, Bin S. Teh, Thanh Van et al. · International Journal of Radiation Oncology*Biology*Physics · 2003 · 67 citations

Adaptive Radiotherapy, Oncology, Health Sciences +11

Evaluation of Patients after Extraperitoneal Lymph Node Dissection and Subsequent Radiotherapy for Cervical Cancer

Annette Hasenburg, Joseph K. Salama, Thanh Van et al. · Gynecologic Oncology · 2002 · 44 citations

Cervical Cancer Management, Gynecological Surgery, Cervical Cancer +10

IMRT versus conventional 3DCRT on prostate and normal tissue dosimetry using an endorectal balloon for prostate immobilization

María T. Vlachaki, T. Teslow, Chad M. Amosson et al. · Medical dosimetry · 2005 · 42 citations

Urology, Brachytherapy, Conventional 3Dcrt +6

Impact of setup uncertainty in the dosimetry of prostate and surrounding tissues in prostate cancer patients treated with Peacock/IMRT

Salahuddin Ahmad, María T. Vlachaki, T. Teslow et al. · Medical dosimetry · 2005 · 14 citations

Urology, Medicine, Prostate Cancer Patients +9

Using technology to decrease xerostomia for head and neck cancer patients treated with radiation therapy

Chad M. Amosson, Bin S. Teh, Shiao Y. Woo et al. · Seminars in Oncology · 2002 · 13 citations

Neck Cancer Patients, Radiation Therapy, Medicine +10